sodium-retaining steroid, it is logical to question its role in this particular disorder. An abnormal increase of aldosterone excretion in patients with the sodium-losing form of the syndrome suggested an action on the renal tubules of unknown steroids promoting sodium excretion (2) . The hypersecretion of aldosterone was thought to be compensatory, and the sodium-losing compounds were sought among the steroids or degradation products of steroids appearing on the biosynthetic pathway before the site of the defect (5) (6) (7) (8) . If such steroids are indeed responsible for the sodium loss, it follows that the sodium loss should disappear when abnormal steroid production is prevented by suppression of ACTH secretion.
An abnormal decrease of aldosterone secretion in the syndrome, on the other hand, provides an immediate explanation for the sodium loss. In the present investigation, carbohydrate-active steroids were administered to assure inhibition of ACTH secretion. Aldosterone production was assessed by radioisotopic measurement of secretion and urinary excretion.
Methods
Patients. Eight patients with salt-losing congenital adrenal hyperplasia were included in this study. The criteria for this diagnosis were 1) abnormally high urinary excretion of 17-ketosteroids (17-KS) and pregnanetriol before treatment, 2) low or normal urinary excretion of 17-hydroxycorticosteroids (17-OHCS), showing little or no increase with ACTH given over 5-day periods, 3) hyperkalemia and hyponatremia before treatment, 4) restoration of urinary 17-KS to normal with carbohydrate-active steroids, and 5) restoration of serum potassium and sodium to normal with desoxycorticosterone acetate (DOCA). The t Children without adrenal disorder show no detectable pregnanetriol by this method.
had separate vaginal and urethral openings at the in-during initial observations and as frequently as possible troitus, and clitoral hypertrophy. Testes were palpable during the period of sodium deprivation. E.J. received in the scrotum of each of the other cases. Hyperpig-no exogenous steroids during the study reported here. mentation of nipples and scrotum was present in three During another study, however, when he received 0.2 mg cases. All of the patients had received treatment with of dexamethasone and 20 mEq of sodium a day, he was steroids before admission to the Clinical Center. Ele-excreting sodium at the intake level 8 days later and vated quantities of pregnanetriol were found in the urine developed vomiting as his serum sodium fell to 122 mEq of all patients. Seven patients without adrenal dysfunc-per L. His urinary 17-KS on the eighth day were 0.9 tion were included as controls (Table II) . mg per 24 hours confirming ACTH suppression. Procedures. Cortisol, prednisone, or prednisolone was Blood was obtained at 2-to 7-day intervals from a fegiven to the patients in constant amounts throughout each moral or antecubital vein without stasis and analyzed for study except that on E.J. (Table III) . The control pa-hematocrit and for serum sodium, potassium, chloride, bitients had been shown to excrete normal amounts of carbonate, and urea nitrogen concentrations. A sample 17-OHCS and did not receive exogenous steroids. The diet and 24-hour pools of urine were analyzed for sodium patients received no DOCA during the study and had and potassium. Stools from B.L., W.G., K.M., and received no desoxycorticosterone trimethyl acetate for J.D. were also analyzed for sodium and potassium. more than 4 weeks before hospitalization. Sodium chlo-Body weight was measured to the nearest gram at the ride was added to a constant, low-sodium diet in an same time each day. The control patients were studied amount sufficient to maintain sodium balance during the by identical procedures, except that the initial sodium "control" periods. The sodium intake was then decreased intake was less and that no exogenous steroids were and kept constant until signs of sodium depletion were given. evident. Twenty-four hour urine collections were made Aldosterone secretion was determined by a modification 4Kindly provided by Dr. R. Gaunt, Ciba Pharmaceuticals, Summit, N. J. 5 New England Nuclear Corp., Boston, Mass.
final spot was eluted, and the content of carbon" and tritium was measured in a liquid scintillation spectrometer. 6 The adequacy of purification by four chromatographic separations was demonstrated by three secretion rate determinations in patients with Addison's disease. The net yields of carbon" were 0, 1, and 3 cpm above background, and the yields of tritium were 3,370, 6,870, and 4,980 cpm, respectively. The calculated secretion rates were 0, 0.3, and 1.4 jsg per 24 hours. As shown in Table IV , there are significant decreases in the final secretion rate as calculated after the fourth, as compared to the third, chromatographic separation. These data (Table IV) were obtained by removing a sample of the aldosterone monoacetate after the third chromatography.
Specific activity of the acetic-i-C" anhydride was determined as described by Kliman and Peterson (10) Hematocrit was determined on venous blood by the micromethod. Serum and urinary sodium and potassium were measured by flame photometry. Blood urea nitrogen was measured by the autoanalyzer. Urinary 17-KS were measured by the Zimmerman reaction (11) and pregnanetriol by the method of Bongiovanni and Eberlein (12) .
Results
The results are shown in Figures 1 and 2 (Table III) . Serum potassium increased in all patients except B.S., in whom a single value of 5.4 mEq per L was obtained while she was clinically in severe crisis, and E.J., in whom control levels were already 6.8 mEq per L. Figure 1 shows the changes in serum sodium, serum potassium, body weight, and hermiatocrit and compares them with corresponding values for the subjects without adrenal dysfunction. A single control patient with gastroenteritis continued to vomit, but none of the controls developed hypotension, lethargy, or loss of skin turgor. B) Response of aldosterone secretion to sodium depletion. Figure 2 shows the response of aldosterone secretion to sodium deprivation in seven of the patients with salt-losing adrenogenital syndrome. The response of urinary aldosterone in all eight patients is shown in Table V . Values in the children without adrenal dysfunction are shown for comparison in Table VI . In the patients with the adrenogenital syndrome, the 24-hour secretion rates during the control periods ranged from 2 to 27 ug, with a mean of 10 Mug.
With sodium depletion they ranged from 2 to 78 ug, with a mean of 21 ug. The difference between these two means is not significant (p > 0.1).
In the children without adrenal dysfunction the 24-hour secretion rates during the control periods ranged from 26 to 198 ug, with a mean of 104 ug. With sodium deprivation, they ranged from 110 to 460 MAg, with a mean of 280 pfg. The difference between these two means is significant (p < 0.02).
The difference between the final secretion rates in the sodium-depleted patients with the adrenogenital syndrome and the sodium-deprived control cases is highly significant (p < 0.001). In only one of the patients with the adrenogenital syndrome was the aldosterone secretion rate in the control period as high as the lowest value seen in the normal subjects. With sodium depletion, the aldosterone secretion rate in this patient rose to a value only 28% of the mean increase among the normal subjects and only 66%o of the increase shown with salt deprivation by the two normal subjects who showed the smallest response. The urinary aldosterone (Tables V, VI) showed comparable changes. Although aldosterone excretion increased with sodium depletion in all adrenogenital patients, increase was of borderline statistical significance (t = 2.66, p < 0.05 for the six paired determinations) and probably of no biological significance. In the control children there was a greater increase in aldosterone excretion with sodium deprivation, and the increase is highly significant (p < 0.01). The difference between the excretion values for the two groups of subjects deprived of sodium is also highly significant (p < 0.01). Patient A.S. did not show an increase in urinary aldosterone. This was probably related to a relatively low potassium intake with resulting diminished aldosterone secretion.
Discussion
Continued loss of sodium, with classical laboratory and clinical signs of sodium depletion, de- veloped in all the patients with salt-losing adrenogenital syndrome despite treatment with carbohydrate-active steroid adequate to suppress abnormal ACTH secretion. This suggests that the sodium loss in this syndrome is not dependent on adrenal steroids produced in excess as a result of the enzymatic defect.
If indeed the sodium loss did result from the action of excessive quantities of sodium-losing steroids (and there were no defects in aldosterone secretion), the sodium loss should lead to hypersecretion of aldosterone. When renal sodium loss is induced pharmacologically, as with mercurial diuretics or aldosterone antagonists, such a compensatory increase in aldosterone secretion is regularly seen (13, 14) . In the studies presented here, however, aldosterone secretion was low and remained low despite severe sodium depletion. Whereas such a failure of compensatory hypersecretion of aldosterone provides no support for the concept that "sodium-losing" steroids play an essential part in the syndrome, it does provide in itself an explanation for the continued loss of sodium.
These studies provide further evidence concerning the possible sites of enzymatic defects in the pathogenesis of the sodium-losing form of the adrenogenital syndrome. Current knowledge concerning these sites is outlined in Figure 3 A defect of 21-hydroxylation would explain the abnormalities shown by these patients with sodium-losing form of the syndrome (Figure 3 , "21"). Thus, 21-hydroxylation of 17a-hydroxyprogesterone is required for normal secretion of cortisol and thus for normal regulation of the secretion of ACTH (4). Furthermore, 21-hydroxylation of progesterone is probably required for the normal secretion of aldosterone (17) . A defect of 21-hydroxylation of progesterone would explain the inability of all patients in this study to secrete aldosterone in adequate amounts.
Whereas a defect of 21-hydroxylation of progesterone and of 17a-hydroxyprogesterone will explain the abnormalities of the patients described in the present study, it will not explain the ab- It has been proposed that the block in 21-hydroxylation is more complete in the patients with the sodium-losing form of the disorder than in those with the nonsodium-losing form. Patients with the sodium-losing form of the disorder were shown to excrete little or no tetrahydrocortisone in response to ACTH, whereas those with the nonsodium-losing form excreted small but appreciable amounts (1) . In the complete absence of 21-hydroxylation, the adrenal would be unable to secrete even those relatively small quantities of aldosterone required for normal sodium retention (3, 16 
